SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-23-025640
Filing Date
2023-09-12
Accepted
2023-09-12 09:02:05
Documents
1
Period of Report
2023-09-08

Document Format Files

Seq Description Document Type Size
1 SEPTEMBER 12, 2023 - 4: STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITI rdgdoc.html 4  
1 SEPTEMBER 12, 2023 - 4: STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITI rdgdoc.xml 4 2770
  Complete submission text file 0001437749-23-025640.txt   4641
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Reporting) CIK: 0001429260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38114 | Film No.: 231249099
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Issuer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations